Cargando…
Opportunities and Challenges for In Silico Drug Discovery at Delta Opioid Receptors
The delta opioid receptor is a Gi-protein-coupled receptor (GPCR) with a broad expression pattern both in the central nervous system and the body. The receptor has been investigated as a potential target for a multitude of significant diseases including migraine, alcohol use disorder, ischemia, and...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9324648/ https://www.ncbi.nlm.nih.gov/pubmed/35890173 http://dx.doi.org/10.3390/ph15070873 |